The survey was initiated by HTStec as part of its tracking of this emerging life science marketplace and to update HTStec’s previous report (June 2012). The questionnaire was compiled to meet the needs, requirements and interests of the epigenetic modification vendor community. The objective was to comprehensively document current practices and preferences in epigenetic modification assays, and to understand future user requirements for drug screening against epigenetic proteins both internally and at fee-for-service providers.
Equal emphasis was given to soliciting opinion from Pharma, Biotech and Academic Research market segments in both North America and Europe.
Benchtop Automation Trends Gain a better understanding of current interest in and future deployment of benchtop automated systems. Tuesday, May 24, 2016RNAi Screening Trends Understand current trends and learn which application areas are expected to gain in popularity over the next few years. Friday, July 17, 2015